BACKGROUND: Prospective and case-control studies have demonstrated that memory loss and executive dysfunction occur early in Alzheimer disease (AD). OBJECTIVE: To investigate these observations by the study of persons at risk for autosomal dominant forms of AD. METHODS: Neuropsychological and genetic tests were performed on 51 nondemented at-risk members of 10 Mexican families with two distinct presenilin-1 (PS1) mutations. Test scores were compared between PS1 mutation carriers (MCs; n = 30) and noncarriers (NCs; n = 21) by analyses of variance, co-varying for family and specific mutation. Regression analyses were performed, taking into account age relative to the median age at dementia diagnosis in the family (adjusted age), gender, Beck Depression Inventory (BDI) scores, education, and number of APOE epsilon4 alleles. Subjects were divided into age tertiles and scores compared within these groups. Composite scores for Verbal Memory, Executive Function/Working Memory, Language, and Visuospatial Function were created, and these scores compared between MCs and NCs. RESULTS: MCs performed worse than NCs on the Mini-Mental State Examination, Trails Making Tests A and B, Delayed Recall of a 10-Word List, and Wechsler Adult Intelligence Scale WAIS Block Design. In multiple linear regression analyses, BDI score, gender, and number of APOE epsilon4 alleles did not consistently affect test scores. The differences seen between MCs and NCs were due to differences in the oldest tertile. MCs had lower Visuospatial and Executive Function/Working Memory but not Verbal Memory or Language composite scores. CONCLUSIONS: This study is consistent with findings in sporadic Alzheimer disease of early problems with memory, visuospatial function, and particularly with executive function in PS1 mutation carriers. Depression, gender, and presence of an APOE epsilon4 allele did not demonstrate large influences on neuropsychological performance.
BACKGROUND: Prospective and case-control studies have demonstrated that memory loss and executive dysfunction occur early in Alzheimer disease (AD). OBJECTIVE: To investigate these observations by the study of persons at risk for autosomal dominant forms of AD. METHODS: Neuropsychological and genetic tests were performed on 51 nondemented at-risk members of 10 Mexican families with two distinct presenilin-1 (PS1) mutations. Test scores were compared between PS1 mutation carriers (MCs; n = 30) and noncarriers (NCs; n = 21) by analyses of variance, co-varying for family and specific mutation. Regression analyses were performed, taking into account age relative to the median age at dementia diagnosis in the family (adjusted age), gender, Beck Depression Inventory (BDI) scores, education, and number of APOE epsilon4 alleles. Subjects were divided into age tertiles and scores compared within these groups. Composite scores for Verbal Memory, Executive Function/Working Memory, Language, and Visuospatial Function were created, and these scores compared between MCs and NCs. RESULTS:MCs performed worse than NCs on the Mini-Mental State Examination, Trails Making Tests A and B, Delayed Recall of a 10-Word List, and Wechsler Adult Intelligence Scale WAIS Block Design. In multiple linear regression analyses, BDI score, gender, and number of APOE epsilon4 alleles did not consistently affect test scores. The differences seen between MCs and NCs were due to differences in the oldest tertile. MCs had lower Visuospatial and Executive Function/Working Memory but not Verbal Memory or Language composite scores. CONCLUSIONS: This study is consistent with findings in sporadic Alzheimer disease of early problems with memory, visuospatial function, and particularly with executive function in PS1 mutation carriers. Depression, gender, and presence of an APOE epsilon4 allele did not demonstrate large influences on neuropsychological performance.
Authors: D H Geschwind; J Robidoux; M Alarcón; B L Miller; K C Wilhelmsen; J L Cummings; Z S Nasreddine Journal: Ann Neurol Date: 2001-12 Impact factor: 10.422
Authors: J M Ringman; C Diaz-Olavarrieta; Y Rodriguez; M Chavez; F Paz; J Murrell; M Angel Macias; M Hill; C Kawas Journal: J Neurol Neurosurg Psychiatry Date: 2004-03 Impact factor: 10.154
Authors: T D Bird; S M Sumi; E J Nemens; D Nochlin; G Schellenberg; T H Lampe; A Sadovnick; H Chui; G W Miner; J Tinklenberg Journal: Ann Neurol Date: 1989-01 Impact factor: 11.274
Authors: Jill Murrell; Bernardino Ghetti; Elizabeth Cochran; Miguel Angel Macias-Islas; Luis Medina; Arousiak Varpetian; Jeffrey L Cummings; Mario F Mendez; Claudia Kawas; Helena Chui; John M Ringman Journal: Neurogenetics Date: 2006-08-05 Impact factor: 2.660
Authors: Richard J Caselli; Dona E C Locke; Amylou C Dueck; David S Knopman; Bryan K Woodruff; Charlene Hoffman-Snyder; Rosa Rademakers; Adam S Fleisher; Eric M Reiman Journal: Alzheimers Dement Date: 2013-03-26 Impact factor: 21.566
Authors: John M Ringman; Luis D Medina; Yaneth Rodriguez-Agudelo; Mireya Chavez; Po Lu; Jeffrey L Cummings Journal: Curr Alzheimer Res Date: 2009-08 Impact factor: 3.498
Authors: Lissy Jarvik; Asenath LaRue; Deborah Blacker; Margaret Gatz; Claudia Kawas; John J McArdle; John C Morris; James A Mortimer; John M Ringman; Linda Ercoli; Nelson Freimer; Izabella Gokhman; Jennifer J Manly; Brenda L Plassman; Natalie Rasgon; Jeffrey Scott Roberts; Trey Sunderland; Gary E Swan; Phillip A Wolf; Alan B Zonderman Journal: Alzheimer Dis Assoc Disord Date: 2008 Jan-Mar Impact factor: 2.703
Authors: Jessica B Langbaum; Adam S Fleisher; Kewei Chen; Napatkamon Ayutyanont; Francisco Lopera; Yakeel T Quiroz; Richard J Caselli; Pierre N Tariot; Eric M Reiman Journal: Nat Rev Neurol Date: 2013-06-11 Impact factor: 42.937
Authors: Caitlin S Latimer; Katherine L Lucot; C Dirk Keene; Brenna Cholerton; Thomas J Montine Journal: Annu Rev Pathol Date: 2021-01-24 Impact factor: 23.472
Authors: Julie Gonneaud; Christophe Bedetti; Alexa Pichet Binette; Tammie L S Benzinger; John C Morris; Randall J Bateman; Judes Poirier; John C S Breitner; Sylvia Villeneuve Journal: Neurology Date: 2020-08-05 Impact factor: 9.910